Insider filing · HRTX
Rubric Capital Management LP bought $3.6M of Heron Therapeutics, Inc. /de/ (HRTX)
Executed Aug 8 2025, disclosed Aug 12 2025, 4 days later.
Value, as filed
$3.6M
2,387,225 sh × $1.50
Executed
Aug 8 2025
the trade date, as filed
Disclosed
Aug 12 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
-1.6%
-9.7% from execution
Over the 21 trading sessions from the disclosed entry session (Aug 12 2025), the stock returned -1.6% (delay-adjusted); from the execution session (Aug 8 2025), -9.7%. Derived: entry at the session's open, exit at the close 20 sessions later.
The filer
RL
Rubric Capital Management LP
10% owner
profile →
Rubric Capital Management LP (10% owner) filed 3 Form 4 reports as a reporting entity in the past 24 months (1 purchase, 2 sales), most often in COLL. Across 1 priced purchase filing, the average 21-session return was -9.7% from execution and -1.6% from disclosure (delay-adjusted; derived). The largest single filing was $114.0M of TLN (388,130 sh across 18 lots, as filed), executed Jun 25 2025.
The name
HRTX
HRTX
HRTX · 2 filings in 24 months
ticker →
Insider filings, newest first→
View the original filing at www.sec.gov→